Sanofi SA (ADR) (NYSE:SNY), saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 2,473,522 shares, a drop of 43.8% from the March 31st total of 4,402,961 shares, Stock Ratings News reports. Based on an average daily trading volume, of 2,245,371 shares, the days-to-cover ratio is presently 1.1 days. Approximately 0.0% of the company’s shares are sold short. Sanofi SA (ADR) (NYSE:SNY), net profit margin is 9.30% and weekly performance is 2.15%. On last trading day company shares ended up $53.10. Analysts mean target price for the company is $57.88. Sanofi SA (ADR) (NYSE:SNY), distance from 50-day simple moving average (SMA50) is 5.02%.
On May 15, 2014, Actavis plc (NYSE:ACT), announced that it has reached an agreement with Janssen Pharmaceuticals, Inc. (JPI) to continue supplying the authorized generic version of JPI’s Concerta® (methylphenidate hydrochloride extended-release tablets). Actavis plc (NYSE:ACT), advanced 0.95% in last trading session and ended the day on $207.50. ACT, Gross Margin is 45.90% and its return on assets is -4.70%. Actavis plc (NYSE:ACT), quarterly performance is 8.14%.
On May 15, 2014, Bayer AG (ADR) (OTCMKTS:BAYRY), said it agreed to sell its Interventional device business to Boston Scientific (BSX.N) for $415 million in cash, a deal that is expected to close in the second half of 2014. Bayer AG (ADR) (OTCMKTS:BAYRY), shares moved down 0.03% in last trading session and was closed at $141.76, while trading in range of $140.51 – $142.00.
On May 15, 2014, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), announced the financial results of the Q1 year 2014 recently. According to the news, the company managed total revenue of $5.0 billion which is 2% higher than the revenues that this company generated a year back in Q1 of 2013. When it comes to net income part, the company managed to earn $1.0 billion net income if taken into consideration GAAP. The cash income of the company was $744 million. The GAAP income grew at a rate of 8% while non GAAP (cash) income grew at a rate of 18% on YOY basis. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), ended the last trading day at $49.81. Company weekly volatility is calculated as 1.89% and price to cash ratio as 54.60. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), showed a positive weekly performance of 1.14%.
One of the leading player in the biopharmaceutical domain, Bristol-Myers Squibb Co (NYSE:BMY), has recently introduced a range of breakthrough products and therapies. Addressing the needs of millions of patients that are struggling with fatal cancerous disease, it has provided a unique savior at their disposal. It is determined to make further innovational leaps in the near future. Bristol-Myers Squibb Co (NYSE:BMY), net profit margin is 17.70% and weekly performance is -4.69%. On last trading day company shares ended up $48.78. Analysts mean target price for the company is $55.06 Bristol-Myers Squibb Co (NYSE:BMY), distance from 50-day simple moving average (SMA50) is -5.07%.